🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a 12-week, multicenter, randomized, double-blind, placebo-controlle...
Status
Terminated
Location
Phoenix
Start Date
2017-03-27
Trial ID
NCT03062540
Treatments Being Tested
This is a 12-week, multicenter, randomized, double-blind, placebo-controlle...
Status
Terminated
Location
Ashild Peters
Start Date
2019-03-07
Trial ID
NCT03841773
Treatments Being Tested
This is a 12-week study that will test the safety and efficacy of asenapine...
Status
Completed
Location
Multiple Locations
Start Date
2005-06-02
Trial ID
NCT00145470
This is a Phase 2, randomized, parallel-group, double-blind, placebo-contro...
Status
Completed
Location
Accel Research-Birmingham Clinical Research Unit
Start Date
2022-08-18
Trial ID
NCT05472090
Treatments Being Tested
Phase III, randomized, double-blind, double-dummy, active-controlled, paral...
Status
Completed
Location
Parkway Medical Center
Start Date
2015-12
Trial ID
NCT02651584
Treatments Being Tested
To evaluate the efficacy of ramelteon for treatment of acute depressive epi...
Status
Terminated
Location
Multiple Locations
Start Date
2012-08
Trial ID
NCT01677182
Our proposal is to administer asenapine to patients who are clinically agit...
Status
Completed
Location
St. Joseph's Hospital Health Center-Comprehensive Psychiatric Emergency Program (CPEP)
Start Date
2012-04
Trial ID
NCT01400113
The primary objective of the study is to demonstrate maintenance of treatme...
Status
Completed
Location
Multiple Locations
Start Date
2014-07
Trial ID
NCT02180659
Participants who have completed the 3-week trial P05691 (NCT00764478) can b...
Status
Completed
Location
Forest Investigative Site 1000
Start Date
2012-04
Trial ID
NCT01395992
To evaluate the efficacy and safety of once a day ramelteon tablets for sub...
Status
Withdrawn
Location
Multiple Locations
Start Date
2012-09
Trial ID
NCT01685151
Treatments Being Tested